Kuala Lumpur, Malaysia | July 18, 2025 — From July 16 to 18, WHX Kuala Lumpur 2025, one of ASEAN’s most influential exhibitions for medical devices and laboratory equipment, took place in the Malaysian capital. The event gathered global healthcare technology leaders, and Singclean Medical, a leading Chinese in-vitro diagnostics (IVD) company, made a strong impression with its innovative and reliable total IVD solutions. Backed by solid product performance and technological excellence, Singclean attracted wide interest and recognition from professional attendees.

ASEAN-Focused, Globally Trusted: Singclean IVD Solutions in the Spotlight
As a key gateway to the Southeast Asian market, WHX Kuala Lumpur 2025 welcomed hundreds of exhibitors and tens of thousands of medical professionals.
Singclean Medical showcased a diverse portfolio of IVD products tailored to local healthcare needs at its central booth, drawing significant attention with offerings such as:
Fertility Testing | Supporting precision reproductive health management
Infectious Disease Testing | High-sensitivity, rapid detection solutions
The booth attracted numerous hospital executives, lab specialists, distributors, and procurement professionals from across Malaysia, Indonesia, Vietnam, Thailand, and beyond. Many visitors praised Singclean's offerings for their technological innovation, product reliability, and cost-effectiveness, underscoring their suitability for strengthening primary care and tackling regional disease burdens.
Global Vision, Local Commitment: Empowering Healthcare in ASEAN
Singclean’s success at WHX Kuala Lumpur was more than a product showcase—it demonstrated the company’s commitment to a “global vision with local dedication.” By understanding the unique disease profiles, healthcare systems, and user expectations across Southeast Asia, Singclean continues to deliver high-quality, accessible diagnostic solutions that meet real-world needs.
“We’re excited to connect with our Southeast Asian partners and clients through such a prestigious platform,”
said the International Business Director of Singclean Medical.
“The positive feedback we’ve received affirms our direction. Moving forward, we’ll deepen our R&D investment and enhance our support to offer more localized, innovative IVD products and services.”

Strengthening Market Presence, Enabling Future Collaboration
This exhibition not only enhanced Singclean Medical’s professional presence across ASEAN, but also laid a solid foundation for deeper cooperation and market expansion in the region.
With innovation as its driver and customer needs at the core, Singclean Medical remains committed to delivering superior healthcare solutions globally—especially to fast-growing markets like Southeast Asia.
-
singclean | 2025-07-29
Singclean to Showcase Aesthetic Manufacturing Excellence and Singderm Brand Strength at IMCAS 2026 -
singclean | 2025-07-29
Singclean Medical Strengthens Its Market Position at Russian Health Care Week 2025Singclean Medical successfully concluded its participation in Russian Health Care Week 2025, reinforcing its position as a comprehensive and reliable global supplier in the aesthetic and medical device industry. The exhibition served as a strategic platform for the company to showcase its diversified product portfolio, strong innovation capability, and growing influence in the Russian and neighboring markets. -
singclean | 2025-07-29
Singclean Medical to Present at IMCAS 2026 and Advance Global Academic EngagementSingclean Medical will make a strong appearance at IMCAS World Congress 2026, taking place in Paris, France from January 29 to 30, 2026, further reinforcing its commitment to innovation and academic development in the aesthetic medical field.